RankAlpha logo
Back to Rankings

AARD

Aardvark TherapeuticsD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
AARD vs peer average
34/100
AARD vs. peer average (D vs. C)
Grade spread
A 1 · B 3 · C 1 · D 1 · F 2
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

HURA is the first available peer comparator.

A similar-market-cap biotechnology reference only; the packet supplies no matching indication, modality, clinical stage, or runway evidence, so it is not a direct valuation comparator.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerHURATuHURA Biosciences
AARD
Aardvark Therapeutics
HURA
TuHURA Biosciences
Grade
D
B
Momentum
91
98
Value
41
41
Sentiment
45
76
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive

Grade position vs HURA

AARD / HURA
Grade Position
Below peers
AARD vs. peer average (D vs. C)
34/100
Momentum
91
HURA
Value
41
AARD
Sentiment
45
HURA

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs AARD
1
HURA
HURA
B
80/100
-2
2
LENZ
LENZ
B
80/100
-2
3
NRXP
NRXP
C
60/100
-1
4
TLSA
Tiziana Life Sciences Ltd Common
F
20/100
+1
5
MENS
Jyong Biotech Ltd Common
F
20/100
+1
HURA is the first peer returned for this comparison set.